2023 annual financial data
Caribou Biosciences 2023 Operating margin
Direct answer
Operating margin was -336.63%.
Operating income was -116,059,000 USD and net income was -102,070,000 USD.
Operating cash flow was -93,291,000 USD.
Get free Caribou Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34,477,000 USD
- Operating income
- -116,059,000 USD
- Net income
- -102,070,000 USD
- Operating cash flow
- -93,291,000 USD